In MYCN-driven human brain tumor models generated from primary embryonic or induced pluripotent stem cell (iPSC)-derived neural stem cells we could show a significant correlation of mTOR pathway activation and OCT4 levels (52). This evidence concerns the gene MYCN and brain neoplasm.